Heron's (HRTX) Sustol For Chemotherapy-Induced Nausea Approved By FDA In Third Attempt - International Business Times

International Business Times

Heron's (HRTX) Sustol For Chemotherapy-Induced Nausea Approved By FDA In Third Attempt International Business Times The U.S. Food and Drug Administration finally approved Heron Therapeutics Inc.'s long-acting injection to prevent chemotherapy-induced nausea and vomiting that had previously been rejected two times. There will be about 1,685,210 new cases of cancer in ... FDA approves extended-release anti-nausea drugPharmacy Today, American Pharmacists Association, pharmacist.com FDA approves Heron's therapy for chemotherapy-induced nauseaReuters FDA Approved Heron's Sustol To Prevent Chemotherapy Induced Nausea and VomitingScience World Report PerfScience -FierceBiotech -OncLive -Tech Times all 33 news articles »

Heron's (HRTX) Sustol For Chemotherapy-Induced Nausea Approved By FDA In Third Attempt - International Business Times
Read More